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Mark T. Kearney, MD, MBCHB,† Nicholas Gall, MSC, MD,* Qing Zhang, BM, MM,‡
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London and Leeds, United Kingdom; and Chengdu and Hong Kong, China
O B J E C T I V E S This study investigated the use of 3-dimensional (3D) echo in quantifying left ventricular
mechanical dyssynchrony (LVMD), its interhospital agreement, and potential impact on patient selection.
B A C KG ROUND Assessment of LVMD has been proposed as an improvement on conventional
criteria in selecting patients for cardiac resynchronization therapy (CRT). Three-dimensional echo offers
a reproducible assessment of left ventricular (LV) structure, function, and LVMD and may be useful in
selecting patients for this intervention.
METHOD S We studied 187 patients at 2 institutions. Three-dimensional data from baseline and
longest follow-up were quantiﬁed for volume, left ventricular ejection fraction (LVEF), and systolic
dyssynchrony index (SDI). New York Heart Association (NYHA) functional class was assessed indepen-
dently. Several outcomes from CRT were considered: 1) reduction in NYHA functional class; 2) 20%
relative increase in LVEF; and 3) 15% reduction in LV end-systolic volume. Sixty-two cases were shared
between institutions to analyze interhospital agreement.
R E S U L T S There was excellent interhospital agreement for 3D–derived LV end-diastolic and end- systolic
volumes, EF, and SDI (variability: 2.9%, 1%, 7.1%, and 7.6%, respectively). Reduction in NYHA functional class
was found in 78.9% of patients. Relative improvement in LVEF of 20% was found in 68% of patients, but
signiﬁcant reduction in LV end-systolic volume was found in only 41.5%. The QRS duration was not predictive
of any of themeasures of outcome (area under the curve [AUC]: 0.52, 0.58, and 0.57 for NYHA functional class,
LVEF, and LV end-systolic volume), whereas SDI was highly predictive of improvement in these parameters
(AUC: 0.79, 0.86, and 0.66, respectively). For patients not fulﬁlling traditional selection criteria (atrial ﬁbrillation,
QRS duration 120 ms, or undergoing device upgrade), SDI had similar predictive value. A cutoff of 10.4%
for SDI was found to have the highest accuracy for predicting improvement following CRT.
CONC L U S I O N S The LVMD quantiﬁcation by 3D echo is reproducible between centers. SDI was an
excellent predictor of response to CRT in this selected patient cohort and may be valuable in identifying
a target population for CRT irrespective of QRS morphology and duration. (J Am Coll Cardiol Img 2011;
4:16–26) © 2011 by the American College of Cardiology Foundation
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17ardiac resynchronization therapy (CRT)
has emerged as an important therapeutic
intervention in the treatment of chronic
heart failure. In multicenter trials, selected
atients with chronic heart failure undergoing CRT
xperience significant improvement in both markers
f subjective well-being and echo parameters of
ardiac function as well as clinical end points such
s hospitalization for heart failure and death (1–6).
election criteria in trials of CRT have been rela-
ively uniform in identifying patients with symp-
omatic chronic heart failure (New York Heart
ssociation [NYHA] functional class III or IV on
ptimal medical therapy, left ventricular ejection
raction [LVEF] 35%) and electrocardiographic
ECG) evidence of dyssynchronous LV contraction
prolonged QRS duration [QRSd] with left bundle
ranch block [LBBB] pattern on surface ECG)
7–9). These widely accepted patient selection cri-
eria are, however, associated with a 20% to 30%
onresponder rate.
Nonresponse to CRT may reflect intrinsic char-
cteristics of the heart (i.e., synchrony cannot be
mproved) or inadequacies in conventional CRT
ethods (i.e., synchrony does not improve because
f inability to pace at an appropriate location with
urrent technology). In attempting to identify po-
ential responders to CRT more accurately, studies
xamining various imaging modalities have sug-
ested that there is a correlation between presence
f significant left ventricular mechanical dyssyn-
hrony (LVMD) and positive outcome from CRT.
everal echocardiographic methods in particular
ave appeared promising in a large number of
ingle-center trials. However, a lack of reproduc-
bility in multicenter trials has cast some doubt over
he clinical applicability of these techniques (10–
2). Real-time 3-dimensional echocardiography
RT3DE) has been proposed as an alternative and
otentially more accurate method for quantifying
VMD and identifying patients suitable for CRT
13). Several studies have proven this modality to be
he most accurate echocardiographic method for
uantifying LV volumes and function (14–21),
hich in itself may have an important impact on
linical practice (22).
We previously demonstrated that RT3DE can be
sed to examine and quantify endocardial motion of
ll myocardial segments across their entire surface.
his has allowed us to derive a potentially more
ccurate measure of LVMD called the systolic
yssynchrony index (SDI) (13), which has been
eproduced in multiple later studies (23–30). In this o-center study, we investigate in potential value of
T3DE in patients undergoing CRT, intercenter
ariability in quantification, and the ability of the
echnique to identify responders to this therapy.
E T H O D S
e investigated 187 patients undergoing primary
mplant or upgrade to biventricular pacemakers or
efibrillators between 2004 and 2008 at King’s
ollege Hospital (KCH), London, United King-
om and the Prince of Wales Hospital, Chinese
niversity of Hong Kong (CUHK), Hong Kong,
hina. Data from 62 cases were shared across sites
or interhospital variability assessment.
linical and echocardiographic outcomes
ere recorded at baseline and longest
ollow-up.
atient selection. Patient selection for
RT was guided by traditional criteria:
ormal sinus rhythm with LVEF 35%,
ymptomatic heart failure (NYHA func-
ional class III/IV) on maximal achievable
edical therapy, and QRS prolongation
120 ms) with LBBB pattern on ECG.
t the implanter’s discretion, patients not
ulfilling all these criteria were also con-
idered for biventricular pacing, thus in-
luding some patients with right bundle
ranch block, paced rhythm, QRSd 120
s, or persistent atrial fibrillation. In these
atients, baseline echocardiographic as-
essment of LVMD was also taken into
ccount.
linical assessment. All patients were reg-
larly reviewed by nurse specialists in heart
ailure. Functional capacity was assessed
ccording to the NYHA functional classi-
cation. NYHA functional class was as-
igned before implantation and at each subsequent
isit, without reference to echo findings. Clinical
nformation was retrieved at the end of the obser-
ation period.
chocardiography. RT3DE studies were performed
ith the Sonos 7500 or iE33 systems (Philips
edical Systems, Andover, Massachusetts). Three-
imensional datasets were acquired in the apical
indow with an ECG-gated acquisition as previ-
usly described (13). In patients with arrhythmia,
ncluding atrial fibrillation, multiple acquisitions
ere performed until a dataset with no appreciable
ranslation artifacts could be obtained, as we previ-
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18uantiﬁcation of dyssynchrony. RT3DE acquisi-
ions were analyzed with 4-dimensional LV analysis
Research Arena 2.0, TomTec, Munich, Delaware).
his software is performs 3D endocardial border
racking throughout the cardiac cycle, to provide a
athematical model of the LV volume. This is
egmented into 16 subvolumes corresponding to the
tandard myocardial segments to derive time-
olume curves for each. Time to peak contraction
minimum volume) in each segment is normalized
or the R-R duration, and SDI is defined as the
tandard deviation of these timings, expressed as a
ercentage of cardiac cycle duration.
evice optimization. Atrioventricular delay was ad-
usted 2  1 day after implantation by examination
f LV inflow with pulsed Doppler at the mitral
osition. The average atrioventricular delay was 115 
5 ms. All patients received synchronous biventricular
acing as default after implantation and no adjustment of
he interventricular delay was performed before
ischarge.
utcomes. Several outcomes were taken as positive
esponse to CRT. A reduction in NYHA functional
lass by at least 1 class was considered a positive
linical response. A relative increase in LVEF by
0% was considered a positive echocardiographic
esponse. Reverse remodeling was defined as at least
5% reduction in LV end-systolic volume
LVESV). Empirically, patients often report subjec-
ive improvement despite not reaching these thresh-
lds. A more sensitive measure of outcome—10%
elative increase in LVEF—was therefore also in-
luded on an exploratory basis, though this approaches
he limit of reproducibility of the technique.
nterhospital variability. Three-dimensional echo
as been shown to be highly reproducible in single-
enter studies (13,23,26,27,30). To assess variability
etween centers, 62 datasets were shared between
he 2 participating specialist cardiology centers. To
nsure that methodology was comparable, investi-
ators at CUHK underwent 1 week of intensive
raining with an experienced operator from KCH
rior to the study. For this purpose, 20 datasets
ith a variety of pathologies were analyzed, and at
he end of the training period there was excellent
greement. The datasets—43 from KCH and 19
rom CUHK—were analyzed independently at
oth sites to examine interhospital variability of
nd-diastolic and end-systolic volumes, LVEF, and
DI. To illustrate the impact of image quality of
easurement variability, we assessed this based onumber of missing segments, endocardial defini- cion, and presence of artifacts; datasets were quali-
atively assessed as excellent, average, or poor.
tatistics. Continuous variables are expressed as
ean  SD and compared with parametric (anal-
sis of variance) and nonparametric (Wilcoxon
igned rank and Kruskal-Wallis) tests. Nominal
ariables are expressed as absolute count and per-
entages and compared with the chi-square or
isher exact tests. Correlations were assessed with
inear and polynomial regression.
Outcomes were assessed with logistic regression to
reate receiver-operator characteristic (ROC) and cal-
ulate probability of response for each level of SDI and
RS. Optimal cutoffs were selected as the level with
he highest (sensitivity – [1 – specificity]).
Odds ratios were derived by dichotomous analy-
is based on traditional values for QRSd (120 ms)
nd the observed best cutoff for SDI (10.4%).
Interobserver agreement was assessed with intra-
lass correlation coefficient (ICC), linear regression,
nd Bland-Altman plots; variability was expressed
s mean difference of measurements as well as
djusted for the mean of each pair of measurements.
MP version 7 (SAS Institute Inc., Cary, North
arolina) and PASW Statistics version 18 (SPSS
nc., Chicago, Illinois) were used for statistical
nalyses.
E S U L T S
uring the period from 2004 to 2008, 187 patients
t KCH and CUHK, underwent primary implan-
ation of, or upgrade to, biventricular pacing.
wenty-one patients (11.2%) were excluded due to
imited image quality or rhythm disturbances pre-
enting acquisition of analyzable 3D datasets. Base-
ine and follow-up data were available for 147
atients with 19 patients lost to follow-up. There
ere 116 (78.9%) men, and 103 (70%) patients had
schemic heart disease. The time to longest
ollow-up echo was 7  3 months (median
ollow-up 6 months, shortest follow-up 2 months).
he 2 cohorts had similar baseline QRSd (137 
3 ms vs. 128  30 ms for KCH and CHUK,
espectively, p  0.15) but differed in baseline
YHA functional class (KCH patients in NYHA
unctional class II  9 [6.1%] vs. 9 [50%] for
HUK, chi-square p  0.001) and LVEF (21.5 
.3% vs. 27.6  7.3%, respectively, p  0.0012).
atients lost to follow-up had similar baseline
haracteristics (QRSd: 131  18, p  0.18, LVEF:
4  9.1%, p  0.7). Baseline clinical and echo
haracteristics are shown in Table 1.
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19ompliance with guidelines for patient selection. Sev-
nty (47.6%) patients did not fulfill strict implan-
ation criteria. Of these patients, 24 (16.3%) had
trial fibrillation; 23 (15.6%) had QRSd 120 ms;
nd 9 (6.1%) had NYHA functional class II symp-
oms at the time of implant. Seventeen patients
11.6%) underwent upgrade of pacemaker to biven-
Figure 1. Histogram of Patients Fulﬁlling Standard Criteria
The histogram illustrates the proportion of patients fulﬁlling standa
each exception is shown (some groups overlap). AF-LBBB  propor
traditional implantation criteria; AF-Low NYHA  proportion of pati
class I or II; AF-Moderate LVD  proportion of patients in atrial ﬁbr
AF-Paced  proportion of patients in atrial ﬁbrillation with paced r
tional class I or II; Moderate LVD  left ventricular ejection fraction
PPM Upgrade  proportion of patients with paced rhythm. AF  a
Table 1. Baseline Characteristics for Patients Included in
the Study (n  166)
NYHA functional class 3.0 0.5
Male sex 131 (78.9%)
Age (yrs) 66.4 12.0
Ischemic LVD 116 (70.1%)
LBBB 112 (67.4%)
QRS duration (ms) 136.7 22.0
QRS 120 ms 138 (83%)
Atrial ﬁbrillation 32 (19%)
LVEDV 206.1 73.8
LVESV 164.6 64.6
LVEF (%) 21.5 7.3
SDI (%) 14 5.2
Values are mean  SD or n (%).
LBBB  left bundle branch block; LVD  left ventricular dysfunction; LVEDV 
left ventricular end-diastolic volume; LVEF  left ventricular ejection fraction;
LVESV  left ventricular end-systolic volume; NYHA  New York Heart Associa-
tion; SDI  systolic dyssynchrony index.lar dysfunction; NYHA  New York Heart Association; PPM  permanenricular device (4 of whom also had atrial fibrilla-
ion). These groups are summarized in Figure 1.
nterhospital variability. The 62 datasets pooled from
he 2 specialist centers (KCH and CUHK) were
ndependently analyzed at both sites. Five (8.1%) were
eemed to have poor image quality, of which analysis
ould not be completed in 4 cases (6.5%). Of the
emainder, 48 (77.4%) had average image quality and
(14.5%) had excellent image quality.
There was excellent correlation between both
enters for both LV end-diastolic volume (r 0.95,
ean difference: 4.61  23.2 ml, 2.9% variability,
CC: 0.97), LVESV (r  0.95, mean difference:
 19.6 ml, 1% variability, ICC: 0.98), and LVEF
r  0.84, mean difference: 2  4.9%, 7.1%
ariability, ICC: 0.91). There was also very good
greement in quantification of dyssynchrony with
ariability for SDI of 7.6% (r  0.76, mean differ-
nce: 0.07  3.38%, ICC: 0.84). Linear correlation
nd Bland-Altman plots demonstrate the excellent
nterhospital agreement (Fig. 2).
utcomes from CRT. The overall clinical and echo-
ardiographic outcomes were consistent with pub-
ished findings. At the latest follow-up (mean 7 
months following implantation), 116 (78.9%)
atients were reported as having subjective im-
riteria. In patients not fulﬁlling standard criteria the proportion of
of patients in atrial ﬁbrillation that would have otherwise fulﬁlled
in atrial ﬁbrillation with New York Heart Association functional
on with left ventricular ejection fraction between 35% and 45%;
m; Low NYHA  patients in New York Heart Association func-
ween 35% and 45%; Narrow QRS  QRS duration of 120 ms;
ﬁbrillation; LBBB  left bundle branch block; LVD  left ventricu-rd c
tion
ents
illati
hyth
bet
trialt pacemaker; RBBB  right bundle branch block.
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20rovement with reduction in NYHA functional
lassification by at least 1 class. Ninety-six patients
65.3%) demonstrated a 20% relative increase in
VEF, but only 61 (41.6%) demonstrated a 15%
eduction in LVESV. A smaller increase in LVEF
as found to more closely reflect NYHA functional
lass changes: 123 (83.6%) of patients had a 10%
elative increase in LVEF.
In patients with 20% improvement in LVEF,
here was a highly significant reduction in SDI
SDI: 5.9  4.3%, p  0.0001) and a similar
eduction was also seen in patients with symptom-
tic improvement (mean SDI: 5.9  0.4%, p 
.0001). In patients exhibiting reverse remodeling
ith reduction in LVESV, there was also a signif-
cant reduction in SDI (SDI: 6.1  0.66%, p 
.009). There was a good correlation between
hange in LVEF and change in SDI (linear corre-
ation coefficient: 0.62). There was good linear
orrelation between baseline SDI and increase in
VEF (r  0.55, p  0.0001), whereas the best
orrelation was found to be quadratic (polynomial
t degree  2, r  0.67, p  0.0001), and from the
catter plot, it is obvious this is due to a plateau in
LVEF with increasing SDI (Fig. 3).
No significant difference in clinical or echocardio-
raphic response was noted between male or female
atients with or without ischemic heart disease (2-tail
isher exact test p  0.1 for all comparisons).
redicting outcomes from CRT. Figures 4 and 5 com-
Figure 2. Interhospital Agreement for 3D Echo
Linear regression (top row) and Bland-Altman graphs (bottom row
end-diastolic volume, left ventricular ejection fraction, and SDI betw
Hong Kong. HK Prince of Wales Hospital, Hong Kong; LVEDV  le
fraction; SDI  systolic dyssynchrony index; 3D 3-dimensional.are QRSd and SDI as predictors of response accord- ong to 4 parameters: functional improvement (1
YHA functional class), systolic function (20%
elative improvement in LVEF), remodeling (15%
mprovement in LVESV), and  10% relative im-
rovement in LVEF. Figure 4 shows scatter plots for
RSd and SDI according to response, and in Figure 5,
OC has been calculated for each predictor.
At baseline, QRSd was not significantly different
etween patients that had functional improvement
nd those that did not (QRSd: 137.5  25.9 ms vs.
33.8  25.9 ms, p  0.43), whereas SDI was
ignificantly different between groups at baseline
SDI: 15  4.7 vs. 10.1  5.1, respectively; p 
.0001). This is reflected in the ROC curves, where
he area under the curve (AUC) was 0.52 for QRSd
nd 0.79 for SDI. Based on ROC curves, the optimal
utoff for SDI in predicting response was 10.4%,
hich confers a sensitivity of 90% and a specificity of
7% for predicting reduction in NYHA functional
lassification by 1 class.
Echocardiographic improvement with 20% rela-
ive increase in LVEF was seen in 96 patients (29.2%
onresponder rate). Baseline QRSd was 139.5 23.4
s vs. 133.8  22.8 ms for responders and nonre-
ponders, respectively (p  0.19). Between groups,
DI at baseline was significantly different (16.2 
.7% vs. 10.6  4.4%, respectively, p  0.0001). In
OC analysis, the AUC for QRSd was 0.57, whereas
t was significantly higher for SDI at 0.86. The
monstrating the agreement in quantiﬁcation of 3-dimensional
King’s College Hospital, London, and Prince of Wales Hospital,
ntricular end-diastolic volume; LVEF  left ventricular ejection) de
een
ft veptimum SDI cutoff for this outcome was 11.4%,
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21hich has a sensitivity of 91% and specificity of 71%
or predicting a significant increase in LVEF after CRT.
Only 41.6% of patients in our cohort demon-
trated a 15% reduction in LVESV. Despite
ignificant overlap, there was a statistically signifi-
ant difference in baseline SDI but not QRSd
Figure 3. Change in SDI and LVEF After CRT
(A) Scatter plot illustrating the change in systolic dyssynchrony inde
dyssynchrony index difference denote reduction, p  0.001). (B) Inc
nization therapy correlates well with reduction in systolic dyssynchr
lates well with systolic dyssynchrony index. The red line illustrates
line ﬁt) with dark blue areas showing conﬁdence intervals for mea
and lower 95% conﬁdence limits for an individual predicted value,
diac resynchronization therapy; EF20  20% relative increase in eje
Figure 4. Baseline QRS Duration and SDI in Responders and No
Scatter plots for QRS duration (top row) and systolic dyssynchrony
sponders by New York Heart Association functional class, 20% relat
ventricular end-systolic volume, and 10% relative increase in left ve
differentiate between groups, whereas systolic dyssynchrony index
in ejection fraction; ESV15  15% reduction in end-systolic volume; othetween responders and nonresponders to this out-
ome (p  0.02). AUC for QRSd was 0.57, versus
.66 for SDI. The optimal SDI cutoff was 11.4%,
onferring a sensitivity of 92% and specificity of 43%.
The greatest difference between responders and
onresponders was seen in the exploratory measure
responders versus nonresponders (positive values for systolic
e in left ventricular ejection fraction following cardiac resynchro-
index. (C) Increase in left ventricular ejection fraction also corre-
r correlation. The blue line illustrates polynomial correlation (best
e, and polynomial ﬁts, and lighter blue areas showing the upper
cting variation in the error and parameter estimates. CRT  car-
fraction; ∆  difference; other abbreviations as in Figure 2.
ponders
x (bottom row) illustrating distribution in responders and nonre-
ncrease in left ventricular ejection fraction, 15% reduction in left
ular ejection fraction. In all comparisons, QRS duration did not
signiﬁcantly higher in responders. EF10  10% relative increasex in
reas
ony
linea
n, lin
reﬂenres
inde
ive i
ntric
waser abbreviations as in Figures 1, 2, and 3.
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22f outcome of a 10% relative increase in LVEF,
hich also appears to more closely correlate to
YHA response as the optimal SDI cutoff was
imilar (10.7%). Baseline QRSd was similar be-
ween groups (p  0.69), whereas there was a
ignificant difference in SDI (15.5  4.8 vs. 7.9 
.4% for responders and nonresponders, respectively,
 0.0001) (Fig. 4). For SDI, AUC was 0.96, and
he optimal cutoff of 10.7% conferred a sensitivity of
9% and specificity of 99% for this outcome.
atients not conforming to traditional criteria. A small
roportion of our cohort had persistent AF at
mplantation (n  19), paced rhythm (n  17),
nd/or QRSd 120 ms (n  33). Although the
tudy design does not allow definitive investigation of
utcomes in these groups, we observed similar out-
omes to those stated with respect to clinical echocar-
iographic and remodeling responses after CRT.
In patients with AF, we observed similar out-
omes to patients with normal sinus rhythm. QRSd
as similar in both responders and nonresponders
n all outcomes (p  0.28 for all comparisons),
hereas SDI was significantly higher in responders
y improvement in NYHA functional class and in
VEF (p  0.02 and p  0.008, respectively), but
Figure 5. Predictive Value of Baseline QRS Duration and SDI in
Receiver-operator characteristic curves for prediction of outcome by
tive increase in left ventricular ejection fraction, 15% reduction in le
ventricular ejection fraction. Systolic dyssynchrony index (solid line
tion (dotted line) showed no predictive value with area under the
LVESV  left ventricular end-systolic volume; TPF  true positive frot by reduction in LVESV (p  0.3). sIn patients with paced rhythm undergoing CRT
pgrade, QRSd was significantly higher (151.2 vs.
34.8 ms, p  0.006), whereas baseline NYHA
unctional class, LV end-diastolic volume, LVEF,
nd SDI were similar to nonpaced subjects (p 0.7
or all comparisons), although no paced patients
ad an SDI of less that 10.4%. The observed
esponse rate was similar across all outcomes.
Baseline QRSd was not statistically different be-
ween any of these groups (p  0.22). Baseline SDI
as not significantly different in patients with and
ithout remodeling (p 0.48) and showed a trend to
ifference in those with clinical response (p  0.07).
owever, there was a statistically significant difference
etween echo responders (p  0.009).
robabilistic nature of SDI. Using logistic regression
nd ROC curves for predicting a 20% relative
ncrease in LVEF, the probability of a positive
esponse was calculated for each level of QRSd and
DI and was plotted against these parameters (Fig. 6).
or SDI, unit odds ratio was 0.236 and range odds
atio 0.0001. For QRSd, the unit odds ratio was
.996 and range odds ratio was 0.599. Though the
lot is nearly linear for QRS, illustrating that a wide
f QRSd have the same probability, there is a
comes After CRT
uction in New York Heart Association functional class, 20% rela-
entricular end-systolic volume; and 10% relative increase in left
rformed signiﬁcantly better in all comparisons, whereas QRS dura-
e of close to 0.5 for all comparisons. FPF  false positive fraction;
n; other abbreviations as in Figures 1, 2, and 3.Out
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23t becomes apparent that above an SDI of 10.4%,
here is a high probability of responding that does
ot increase significantly with higher SDI. Below
.5%, there is a low probability of response, which
oes not reduce further with lower SDIs. Using
DI and QRSd as dichotomous variables with a
utoff of 10.4% and 120 ms, respectively, odds ratios
or improvement in LVEF were 147 (27.47 to
86.67) and 0.62 (0.2 to 1.92), respectively.
ow would 3D echo have inﬂuenced patient selection?
pplying selection criteria retrospectively to this
opulation, if only patients meeting traditional
riteria (sinus rhythm and either QRSd150 ms or
RSd 120 with echo evidence of dyssynchrony)
ere included, then this would have resulted in a
igher response rate (88.3% functional improvement,
0.6% systolic function, and 47.1% remodeling) and
xcluding 47.6% of the cohort, of which 48 (68.6% of
hose not fulfilling these criteria), 34 (59.6%), and 20
35.1%) would have responded by NYHA functional
lass, LVEF, and ESV, respectively.
Applying stricter ECG criteria to include only
atients with sinus rhythm and QRSd 150 ms
ould have resulted in a similar response rate (80%,
5%, and 47.2%, respectively) at the cost of exclud-
ng 72.8% of the cohort, of which 84 (78.5% of
hose not fulfilling these criteria), 55 (61.8%), and
5 (39.3%) would have responded by NHYA func-
ional class, LVEF, or ESV, respectively.
Subselection of this cohort using LVMD only
with an SDI10.4%), and including patients with
trial fibrillation and all QRSd, would have resulted
n a much higher response rate in all outcomes
90.3%, 81%, and 51%, respectively), and excluding
nly 28% of the cohort, of which 10 (34.8% of those
Figure 6. Probability of a Positive Response to CRT Predicted b
QRS duration (A) does not predict response, as probabilities are sim
shows a sigmoid probability curve with values of 7.5% correspon
respond to a very high probability; there is a “gray zone” between
respond to large changes in probability and is therefore less reliabl
Using inverse prediction, the mean and 95% conﬁdence limits for p
probability of positive response (C). Abbreviations as in Figures 2 aot fulfilling this criterion) would have responded py NYHA functional class. No responders by
VEF or LVESV would have been excluded.
I S C U S S I O N
he current study investigates the value of SDI in
he largest cohort so far of patients undergoing
RT to be investigated with RT3DE. The key
ndings of this study are: 1) 3D quantification of
V volumes, function, and LVMD is reproducible
cross centers; 2) in patients already selected for
RT, QRSd is not predictive of either clinical or
chocardiographic outcomes, whereas SDI is highly
redictive; 3) patients with atrial fibrillation or
ormal QRSd but with high SDI have comparable
utcomes to those selected by traditional criteria; and
) the occurrence of reverse LV remodeling, as de-
cribed by a 15% reduction in LVESV, was much
ower than anticipated based on published studies and
id not reflect clinical improvement, suggesting that
his may not be an adequate measure of outcome.
In keeping with previous reports, quantification of
olumes and ejection fraction by 3D echo is accurate
nd highly reproducible, which is reflected in the very
igh interobserver agreement between centers in the
urrent study. The large cohort selected for analysis
ad variable image quality reflecting real-life results.
ewer than 10% of cases had poor image quality and
ewer than 15% had excellent image quality. 3D
uantification of LV function would therefore appear
referable to other echocardiographic methods for
erial clinical evaluation of individual patients as well
s quantification of dyssynchrony.
In the current cohort of patients already selected
or CRT, QRSd was found to have no further
S Duration and SDI Plotted Against These Variables
across the range of its values. Systolic dyssynchrony index (B)
to very low chance of responding whereas values of 10.5% cor-
e values where small changes in systolic dyssynchrony index cor-
e histograms along each axis reﬂect the distribution of subjects.
cted systolic dyssynchrony index were estimated for each level of
.y QR
ilar
ding
thes
e. Th
redirognostic value, whereas SDI has highly accurate
i
o
1
fi
p
v

t
1
L
h
a
k
t
b
p
d
i
f
f
o
s
a
t
a
S
w
p
s
(
e
s
s
a
s
b
f
p
t
s
f
p
S
w
a
s
p
t
p
t
f
s
s
a
(
p
i
o
i
p
d
w
3
S
r
t
o
d
i
p
u
C
R
i
f
c
i
u
r
c
R
a
p
R
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 1 , 2 0 1 1
J A N U A R Y 2 0 1 1 : 1 6 – 2 6
Kapetanakis et al.
3D Echo in CRT
24n separating responders from nonresponders for all
utcomes. The best cutoff for SDI was found to be
0.4%, which confers sensitivity 90% and speci-
city of 67% for all outcomes after CRT. SDI
rovides a probabilistic assessment of outcome with
ery high probability of positive response at
10.4% and very low probability at SDI 7.5%.
A recent observational study comparing 16 pa-
ients with dilated cardiomyopathy and LBBB and
6 patients with dilated cardiomyopathy without
BBB to normal subjects found that all patients
ad SDI higher than that of normal subjects (4%)
nd that SDI was independent of QRSd (31), in
eeping with our previous findings (13). The inves-
igators concluded that the lack of differentiation
etween the 2 groups of heart failure patients
roved SDI was not a useful discriminator of
yssynchrony. This study did not, however, exam-
ne clinical outcomes following CRT, and the cutoff
or SDI used was the upper 95% confidence interval
or normal subjects, which is a “normality” thresh-
ld, rather than a “response” threshold. Our current
tudy demonstrates that it is not sufficient to have
bove-normal intraventricular dyssynchrony, but
hat a significantly higher SDI (10.4%) is associ-
ted with positive outcomes. A similar cutoff for
DI has also been found by Soliman et al. (29),
here an SDI 10% was found to be highly
redictive of positive outcome after CRT. Mar-
an et al. (24) identified a much lower cutoff
6.4%), but analyses were performed on a differ-
nt software platform that applies a different
egmentation model to the mathematical repre-
entation of the LV cavity, indicating that cutoffs
re specific to the software platform used.
Approximately one-fifth of our cohort did not
trictly conform to established selection criteria
ut a high SDI indicated a positive outcome
ollowing CRT in most cases in patients with
re-implantation paced rhythm, atrial fibrilla-
ion, or narrow QRS. Current evidence (32,33)
uggests that even patients with low NYHA
unctional class may benefit, but numbers of such
atients in our cohort were too low to assess.
tudy limitations. Data in this study are retrospec-ure. Circulation 2003;107:1985–90. Trial. JAMA 2003;ill inevitably influence the accuracy of sensitivity
nd specificity, particularly in groups not fulfilling
tandard criteria for CRT implantation. It was not
ossible to obtain data from other modalities, such as
issue Doppler, for comparison, as these were not
erformed in a controlled manner in a large propor-
ion of patients. Functional testing was not available
or the majority of the patients. Applying “what if”
cenarios retrospectively is limited by selection bias.
Presence, extent, and localization of myocardial
car tissue has been found to be potentially associ-
ted with reduction in LVESV following CRT
34–36). Although we found SDI to be a stronger
redictor of this outcome after CRT than QRSd,
ts predictive value is significantly lower than for
ther outcomes and perhaps inclusion of scar
nformation will strengthen this. During the study
eriod, no patient underwent pre-implantation car-
iac magnetic resonance imaging, and, therefore, it
as not possible to correlate myocardial scar with
D dyssynchrony and clinical outcomes from CRT.
imilarly, pacing lead position was not recorded
outinely and, therefore, could not be correlated to
he extent of baseline dyssynchrony and clinical
utcomes.
Data in this study were derived from 2 indepen-
ent centers; however, large-scale prospective stud-
es are needed to establish whether this highly
romising technique can be translated to routine
se for patient selection across the world.
O N C L U S I O N S
eal-time 3D echo provides an accurate, reproduc-
ble quantification of LVMD. In patients selected
or CRT, 3D SDI is a superior predictor of out-
omes therapy compared with QRSd and has a role
n further evaluating and monitoring patients
ndergoing this intervention and potentially has a
ole in patients not fulfilling traditional selection
riteria.
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